140 related articles for article (PubMed ID: 3079484)
1. Clinical status of carboplatin.
Canetta R; Franks C; Smaldone L; Bragman K; Rozencweig M
Oncology (Williston Park); 1987 Jul; 1(5):61-70. PubMed ID: 3079484
[TBL] [Abstract][Full Text] [Related]
2. [Organoplatinum compounds. 1987 update].
Extra JM; Espie M; Calvo F; Marty M
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):123-30. PubMed ID: 3290835
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin, an active drug in advanced head and neck cancer.
de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
[TBL] [Abstract][Full Text] [Related]
4. [Second-generation cisplatin analogs].
Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1043-50. PubMed ID: 3551846
[TBL] [Abstract][Full Text] [Related]
5. Whither carboplatin? A replacement for or an alternative to cisplatin?
Gil A
J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520
[No Abstract] [Full Text] [Related]
6. A comparison of the platinum analogues in bladder cancer cell lines.
Powles T; Perry J; Shamash J; Liu W; Oliver T; Joel S
Urol Int; 2007; 79(1):67-72. PubMed ID: 17627172
[TBL] [Abstract][Full Text] [Related]
7. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review).
Boulikas T; Vougiouka M
Oncol Rep; 2004 Mar; 11(3):559-95. PubMed ID: 14767508
[TBL] [Abstract][Full Text] [Related]
8. Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populations.
Belani CP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S10-22. PubMed ID: 19780242
[TBL] [Abstract][Full Text] [Related]
9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the antitumor activity of newly developed platinum analogs in lung cancer using the colony assay].
Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Yamashita H; Kozuka A; Moritaka T; Uji H; Kiura K; Mima Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):427-30. PubMed ID: 2539056
[No Abstract] [Full Text] [Related]
11. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin.
Coughlin CT; Richmond RC
Semin Oncol; 1989 Aug; 16(4 Suppl 6):31-43. PubMed ID: 2669136
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin.
Med Lett Drugs Ther; 1989 Sep; 31(800):83-4. PubMed ID: 2671623
[No Abstract] [Full Text] [Related]
13. Current status and future prospects for satraplatin, an oral platinum analogue.
Choy H; Park C; Yao M
Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
[TBL] [Abstract][Full Text] [Related]
14. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on the anti-tumor effects of CDDP derivatives on head and neck squamous cell carcinoma cell lines].
Tsukuda M; Yoshida T; Kubota A; Yanoma S; Watanabe S; Takahashi K; Ono T; Sawaki S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2811-4. PubMed ID: 3415274
[No Abstract] [Full Text] [Related]
16. Carboplatin: the clinical spectrum to date.
Canetta R; Rozencweig M; Carter SK
Cancer Treat Rev; 1985 Sep; 12 Suppl A():125-36. PubMed ID: 3002623
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin activity in head and neck cancer cell lines.
Espinosa M; Martinez M; Aguilar JL; Mota A; De la Garza JG; Maldonado V; Meléndez-Zajgla J
Cancer Chemother Pharmacol; 2005 Mar; 55(3):301-5. PubMed ID: 15619139
[TBL] [Abstract][Full Text] [Related]
18. Cancer chemotherapy: carboplatin v cisplatin.
Drug Ther Bull; 1987 Aug; 25(17):67-8. PubMed ID: 3308394
[No Abstract] [Full Text] [Related]
19. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
[TBL] [Abstract][Full Text] [Related]
20. [Cisplatinum compounds].
Ota K
Gan To Kagaku Ryoho; 1993 Jan; 20(1):50-8. PubMed ID: 8380687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
